We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Guidance on Protecting Drug, Device Research Subjects
FDA Updates Guidance on Protecting Drug, Device Research Subjects
February 10, 2006
The FDA has revised its guidance on protecting drug and device research subjects in order to help institutional review boards (IRBs), clinical investigators and sponsors fulfill their responsibilities to protect human subjects in clinical trials.